GlaxoSmithKline to Work on TB Drugs

Europe's biggest drugmaker GlaxoSmithKline (GSK) says it is linking with a nonprofit group to seek better tuberculosis treatments. GSK and the Global Alliance for TB Drug Development will work on four projects intended to attack the mycobacterium tuberculosis in new ways at GSK's research laboratories in Spain.

Reuters (http://www.reuters.co.uk/newsArticle.jhtml?type=businessNews&storyID=693859§ion=finance&src=rss/uk/businessNews)